Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 846

1.

Regulatory T Cells Limit Pneumococcus-Induced Exacerbation of Lung Fibrosis in Mice.

Moyé S, Bormann T, Maus R, Sparwasser T, Sandrock I, Prinz I, Warnecke G, Welte T, Gauldie J, Kolb M, Maus UA.

J Immunol. 2020 Mar 25. pii: ji1900980. doi: 10.4049/jimmunol.1900980. [Epub ahead of print]

PMID:
32213566
2.

An autoinhibitory intramolecular interaction proof-reads RNA recognition by the essential splicing factor U2AF2.

Kang HS, Sánchez-Rico C, Ebersberger S, Sutandy FXR, Busch A, Welte T, Stehle R, Hipp C, Schulz L, Buchbender A, Zarnack K, König J, Sattler M.

Proc Natl Acad Sci U S A. 2020 Mar 18. pii: 201913483. doi: 10.1073/pnas.1913483117. [Epub ahead of print]

PMID:
32188783
3.

[S3 guideline sepsis-prevention, diagnosis, treatment, and aftercare : Summary of the strong recommendations].

Brunkhorst FM, Weigand MA, Pletz M, Gastmeier P, Lemmen SW, Meier-Hellmann A, Ragaller M, Weyland A, Marx G, Bucher M, Gerlach H, Salzberger B, Grabein B, Welte T, Werdan K, Kluge S, Bone HG, Putensen C, Rossaint R, Quintel M, Spies C, Weiß B, John S, Oppert M, Jörres A, Brenner T, Elke G, Gründling M, Mayer K, Weimann A, Felbinger TW, Axer H, Heller T, Gagelmann N; Deutsche Sepsis Gesellschaft e. V.

Med Klin Intensivmed Notfmed. 2020 Mar 17. doi: 10.1007/s00063-020-00671-6. [Epub ahead of print] Review. German. No abstract available.

PMID:
32185422
4.

[Recommendations for critically ill patients with COVID-19].

Kluge S, Janssens U, Welte T, Weber-Carstens S, Marx G, Karagiannidis C.

Med Klin Intensivmed Notfmed. 2020 Mar 12. doi: 10.1007/s00063-020-00674-3. [Epub ahead of print] Review. German. No abstract available.

5.

Effect of therapeutic plasma exchange on endothelial activation and coagulation-related parameters in septic shock.

Stahl K, Schmidt JJ, Seeliger B, Schmidt BMW, Welte T, Haller H, Hoeper MM, Budde U, Bode C, David S.

Crit Care. 2020 Mar 2;24(1):71. doi: 10.1186/s13054-020-2799-5.

6.

Extracorporeal cytokine removal in severe CAR-T cell associated cytokine release syndrome.

Stahl K, Schmidt BMW, Hoeper MM, Skripuletz T, Möhn N, Beutel G, Eder M, Welte T, Ganser A, Falk CS, Koenecke C, David S.

J Crit Care. 2020 Feb 19;57:124-129. doi: 10.1016/j.jcrc.2020.02.010. [Epub ahead of print]

PMID:
32113143
7.

Onset of Effect, Changes in Airflow Obstruction and Lung Volume, and Health-Related Quality of Life Improvements with Benralizumab for Patients with Severe Eosinophilic Asthma: Phase IIIb Randomized, Controlled Trial (SOLANA).

Panettieri RA Jr, Welte T, Shenoy KV, Korn S, Jandl M, Kerwin EM, Feijoo R, Barker P, Olsson RF, Martin UJ; SOLANA Study Investigators.

J Asthma Allergy. 2020 Feb 17;13:115-126. doi: 10.2147/JAA.S240044. eCollection 2020. Erratum in: J Asthma Allergy. 2020 Mar 13;13:135.

8.

Respiratory medicine is not gender blind.

Gaga M, Stolz D, Chorostowska-Wynimko J, Welte T, Simonds A.

Eur Respir J. 2020 Jan 23;55(1). pii: 1901847. doi: 10.1183/13993003.01847-2019. Print 2020 Jan. No abstract available.

PMID:
31974119
9.

The impact of COPD on polyneuropathy: results from the German COPD cohort COSYCONET.

Kahnert K, Föhrenbach M, Lucke T, Alter P, Trudzinski FT, Bals R, Lutter JI, Timmermann H, Söhler S, Förderreuther S, Nowak D, Watz H, Waschki B, Behr J, Welte T, Vogelmeier CF, Jörres RA.

Respir Res. 2020 Jan 20;21(1):28. doi: 10.1186/s12931-020-1293-6.

10.

The NLRP3 inflammasome pathway is activated in sarcoidosis and involved in granuloma formation.

Huppertz C, Jäger B, Wieczorek G, Engelhard P, Oliver SJ, Bauernfeind FG, Littlewood-Evans A, Welte T, Hornung V, Prasse A.

Eur Respir J. 2020 Mar 26;55(3). pii: 1900119. doi: 10.1183/13993003.00119-2019. Print 2020 Mar.

PMID:
31949113
11.

[Primary care medicine-Part I : Practice-oriented diagnosis and treatment pathways].

Burchert D, Haller H, Märker-Hermann E, Sieber C, Welte T.

Internist (Berl). 2020 Jan;61(1):1-2. doi: 10.1007/s00108-019-00731-w. German. No abstract available.

PMID:
31925479
12.

Increased frequency of CD4+ CD25high CD127low T cells early after lung transplant is associated with improved graft survival - a retrospective study.

Ius F, Salman J, Knoefel AK, Sommer W, Nakagiri T, Verboom M, Siemeni T, Poyanmehr R, Bobylev D, Kuehn C, Avsar M, Erdfelder C, Hallensleben M, Boethig D, Hecker H, Schwerk N, Mueller C, Welte T, Falk C, Preissler G, Haverich A, Tudorache I, Warnecke G.

Transpl Int. 2020 Jan 6. doi: 10.1111/tri.13568. [Epub ahead of print]

PMID:
31903646
13.

High degree of polyclonality hinders somatic mutation calling in lung brush samples of COPD cases and controls.

Thun GA, Derdak S, Castro-Giner F, Apunte-Ramos K, Águeda L, Wjst M, Boland A, Deleuze JF, Kolsum U, Heiss-Neumann MS, Nowinski A, Gorecka D, Hohlfeld JM, Welte T, Brightling CE, Parr DG, Prasse A, Müller-Quernheim J, Greulich T, Stendardo M, Boschetto P, Barta I, Döme B, Gut M, Singh D, Ziegler-Heitbrock L, Gut IG.

Sci Rep. 2019 Dec 27;9(1):20158. doi: 10.1038/s41598-019-56618-1.

14.

Adherence is associated with a favorable outcome after lung transplantation.

Bertram A, Fuge J, Suhling H, Tudorache I, Haverich A, Welte T, Gottlieb J.

PLoS One. 2019 Dec 17;14(12):e0226167. doi: 10.1371/journal.pone.0226167. eCollection 2019.

15.

Chronic progressive pulmonary paracoccidioidomycosis in a female immigrant from Venezuela.

Kayser M, Rickerts V, Drick N, Gerkrath J, Kreipe H, Soudah B, Welte T, Suhling H.

Ther Adv Respir Dis. 2019 Jan-Dec;13:1753466619894913. doi: 10.1177/1753466619894913.

16.

High-sensitivity troponin I and all-cause mortality in patients with stable COPD: an analysis of the COSYCONET study.

Waschki B, Alter P, Zeller T, Magnussen C, Neumann JT, Twerenbold R, Sinning C, Herr C, Kahnert K, Fähndrich S, Blankenberg S, Rabe KF, Welte T, Jörres RA, Vogelmeier CF, Bals R, Watz H; German COSYCONET Cohort.

Eur Respir J. 2020 Feb 27;55(2). pii: 1901314. doi: 10.1183/13993003.01314-2019. Print 2020 Feb.

PMID:
31831579
17.

Lung-kidney interactions in critically ill patients: consensus report of the Acute Disease Quality Initiative (ADQI) 21 Workgroup.

Joannidis M, Forni LG, Klein SJ, Honore PM, Kashani K, Ostermann M, Prowle J, Bagshaw SM, Cantaluppi V, Darmon M, Ding X, Fuhrmann V, Hoste E, Husain-Syed F, Lubnow M, Maggiorini M, Meersch M, Murray PT, Ricci Z, Singbartl K, Staudinger T, Welte T, Ronco C, Kellum JA.

Intensive Care Med. 2020 Apr;46(4):654-672. doi: 10.1007/s00134-019-05869-7. Epub 2019 Dec 9.

18.

PedCAPNETZ - prospective observational study on community acquired pneumonia in children and adolescents.

Wetzke M, Kopp MV, Seidenberg J, Vogelberg C, Ankermann T, Happle C, Voigt G, Köster H, Illig T, Lex C, Schuster A, Panning M, Barten G, Rohde G, Welte T, Hansen G; pedCAPNETZ Study Group.

BMC Pulm Med. 2019 Dec 9;19(1):238. doi: 10.1186/s12890-019-1013-5.

19.

Morphomolecular motifs of pulmonary neoangiogenesis in interstitial lung diseases.

Ackermann M, Stark H, Neubert L, Schubert S, Borchert P, Linz F, Wagner WL, Stiller W, Wielpütz M, Hoefer A, Haverich A, Mentzer SJ, Shah HR, Welte T, Kuehnel M, Jonigk D.

Eur Respir J. 2020 Mar 12;55(3). pii: 1900933. doi: 10.1183/13993003.00933-2019. Print 2020 Mar.

PMID:
31806721
20.

Generation of a NKX2.1 - p63 double transgenic knock-in reporter cell line from human induced pluripotent stem cells (MHHi006-A-4).

Drick N, Sahabian A, Pongpamorn P, Merkert S, Göhring G, Welte T, Martin U, Olmer R.

Stem Cell Res. 2020 Jan;42:101659. doi: 10.1016/j.scr.2019.101659. Epub 2019 Nov 19.

21.

Pneumococcal conjugate serotype distribution and predominating role of serotype 3 in German adults with community-acquired pneumonia.

Forstner C, Kolditz M, Kesselmeier M, Ewig S, Rohde G, Barten-Neiner G, Rupp J, Witzenrath M, Welte T, Pletz MW; CAPNETZ study group.

Vaccine. 2020 Jan 29;38(5):1129-1136. doi: 10.1016/j.vaccine.2019.11.026. Epub 2019 Nov 21.

PMID:
31761500
22.

CAT score single item analysis in patients with COPD: Results from COSYCONET.

Marietta von Siemens S, Alter P, Lutter JI, Kauczor HU, Jobst B, Bals R, Trudzinski FC, Söhler S, Behr J, Watz H, Waschki B, Bewig B, Jones PW, Welte T, Vogelmeier CF, Jörres RA, Kahnert K; COSYCONET study group; Names of participating study nurses.

Respir Med. 2019 Nov;159:105810. doi: 10.1016/j.rmed.2019.105810. Epub 2019 Nov 7.

PMID:
31739262
23.

Time-updated resting heart rate predicts mortality in patients with COPD.

Omlor AJ, Trudzinski FC, Alqudrah M, Seiler F, Biertz F, Vogelmeier CF, Welte T, Watz H, Waschki B, Brinker TJ, Andreas S, Fähndrich S, Alter P, Jörres RA, Böhm M, Bals R; German COSYCONET Cohort.

Clin Res Cardiol. 2019 Nov 16. doi: 10.1007/s00392-019-01572-1. [Epub ahead of print]

PMID:
31734762
24.

The association of cognitive functioning as measured by the DemTect with functional and clinical characteristics of COPD: results from the COSYCONET cohort.

von Siemens SM, Perneczky R, Vogelmeier CF, Behr J, Kauffmann-Guerrero D, Alter P, Trudzinski FC, Bals R, Grohé C, Söhler S, Waschki B, Lutter JI, Welte T, Jörres RA, Kahnert K; COSYCONET study group.

Respir Res. 2019 Nov 14;20(1):257. doi: 10.1186/s12931-019-1217-5.

25.

Extracorporeal Membrane Oxygenation for Severe ARDS Due to Immune Diffuse Alveolar Hemorrhage: A Retrospective Observational Study.

Seeliger B, Stahl K, Schenk H, Schmidt JJ, Wiesner O, Welte T, Kuehn C, Bauersachs J, Hoeper MM, David S.

Chest. 2020 Mar;157(3):744-747. doi: 10.1016/j.chest.2019.10.021. Epub 2019 Nov 9. No abstract available.

PMID:
31711988
26.

Noncompetitive binding of PpiD and YidC to the SecYEG translocon expands the global view on the SecYEG interactome in Escherichia coli.

Jauss B, Petriman NA, Drepper F, Franz L, Sachelaru I, Welte T, Steinberg R, Warscheid B, Koch HG.

J Biol Chem. 2019 Dec 13;294(50):19167-19183. doi: 10.1074/jbc.RA119.010686. Epub 2019 Nov 7.

PMID:
31699901
27.

Economic analysis of ceftaroline fosamil for treating community-acquired pneumonia in Spain.

Torres A, Bassetti M, Welte T, Rivolo S, Remak E, Peral C, Charbonneau C, Hammond J, Ansari W, Grau S.

J Med Econ. 2020 Feb;23(2):148-155. doi: 10.1080/13696998.2019.1688819. Epub 2019 Nov 26.

PMID:
31686550
28.

Rate and Predictors of Bacteremia in Afebrile Community-Acquired Pneumonia.

Forstner C, Patchev V, Rohde G, Rupp J, Witzenrath M, Welte T, Burgmann H, Pletz MW; CAPNETZ Study Group.

Chest. 2020 Mar;157(3):529-539. doi: 10.1016/j.chest.2019.10.006. Epub 2019 Oct 26.

PMID:
31669433
29.

Maintenance Immunosuppression Is Associated With Better Outcome in the 2017/2018 Influenza Epidemic.

Stahl K, Seeliger B, Busch M, Wiesner O, Welte T, Eder M, Schäfer A, Bauersachs J, Haller H, Heim A, Hoeper MM, David S.

Open Forum Infect Dis. 2019 Sep 24;6(10):ofz381. doi: 10.1093/ofid/ofz381. eCollection 2019 Oct.

30.

[What you can learn from viruses].

Welte T, Vogelmeier CF.

Internist (Berl). 2019 Nov;60(11):1125-1126. doi: 10.1007/s00108-019-00678-y. German. No abstract available.

31.

Adherence To Respiratory And Nonrespiratory Medication In Patients With COPD: Results Of The German COSYCONET Cohort.

Königsdorfer N, Jörres RA, Söhler S, Welte T, Behr J, Ficker JH, Bals R, Watz H, Lutter JI, Lucke T, Biertz F, Alter P, Vogelmeier CF, Kahnert K.

Patient Prefer Adherence. 2019 Oct 10;13:1711-1721. doi: 10.2147/PPA.S223438. eCollection 2019.

32.

Anti-IL5 and anti-IL5Rα therapy for clinically significant bronchiectasis with eosinophilic endotype: a case series.

Rademacher J, Konwert S, Fuge J, Dettmer S, Welte T, Ringshausen FC.

Eur Respir J. 2020 Jan 23;55(1). pii: 1901333. doi: 10.1183/13993003.01333-2019. Print 2020 Jan. No abstract available.

PMID:
31619477
33.

Invasive mould infections in solid organ transplant patients: modifiers and indicators of disease and treatment response.

Welte T, Len O, Muñoz P, Romani L, Lewis R, Perrella A.

Infection. 2019 Dec;47(6):919-927. doi: 10.1007/s15010-019-01360-z. Epub 2019 Oct 1. Review.

PMID:
31576498
34.

Macrolide combination therapy for patients hospitalised with community-acquired pneumonia? An individualised approach supported by machine learning.

König R, Cao X, Oswald M, Forstner C, Rohde G, Rupp J, Witzenrath M, Welte T, Kolditz M, Pletz M; CAPNETZ study group.

Eur Respir J. 2019 Dec 12;54(6). pii: 1900824. doi: 10.1183/13993003.00824-2019. Print 2019 Dec.

PMID:
31537702
35.

The ERS fellowship portfolio: fostering excellence and diversity.

Morty RE, Donnelly LE, Stolz D, Roche N, Welte T, Forrest KA, Brightling CE, Brusselle GG.

Eur Respir J. 2019 Sep 5;54(3). pii: 1901503. doi: 10.1183/13993003.01503-2019. Print 2019 Sep. No abstract available.

PMID:
31488590
36.

Clinical Significance of SERPINA1 Gene and Its Encoded Alpha1-antitrypsin Protein in NSCLC.

Ercetin E, Richtmann S, Delgado BM, Gomez-Mariano G, Wrenger S, Korenbaum E, Liu B, DeLuca D, Kühnel MP, Jonigk D, Yuskaeva K, Warth A, Muley T, Winter H, Meister M, Welte T, Janciauskiene S, Schneider MA.

Cancers (Basel). 2019 Sep 4;11(9). pii: E1306. doi: 10.3390/cancers11091306.

37.

Increasing bronchiectasis prevalence in Germany, 2009-2017: a population-based cohort study.

Ringshausen FC, Rademacher J, Pink I, de Roux A, Hickstein L, Ploner T, Welte T, Diel R.

Eur Respir J. 2019 Dec 4;54(6). pii: 1900499. doi: 10.1183/13993003.00499-2019. Print 2019 Dec. No abstract available.

PMID:
31467114
38.

Immuno-subtyping of breast cancer reveals distinct myeloid cell profiles and immunotherapy resistance mechanisms.

Kim IS, Gao Y, Welte T, Wang H, Liu J, Janghorban M, Sheng K, Niu Y, Goldstein A, Zhao N, Bado I, Lo HC, Toneff MJ, Nguyen T, Bu W, Jiang W, Arnold J, Gu F, He J, Jebakumar D, Walker K, Li Y, Mo Q, Westbrook TF, Zong C, Rao A, Sreekumar A, Rosen JM, Zhang XH.

Nat Cell Biol. 2019 Sep;21(9):1113-1126. doi: 10.1038/s41556-019-0373-7. Epub 2019 Aug 26.

39.

Morphological and molecular motifs of fibrosing pulmonary injury patterns.

Jonigk D, Stark H, Braubach P, Neubert L, Shin HO, Izykowski N, Welte T, Janciauskiene S, Warnecke G, Haverich A, Kuehnel M, Laenger F.

J Pathol Clin Res. 2019 Oct;5(4):256-271. doi: 10.1002/cjp2.141. Epub 2019 Sep 25.

40.

Ceftaroline fosamil as a potential treatment option for Staphylococcus aureus community-acquired pneumonia in adults.

Welte T, Kantecki M, Stone GG, Hammond J.

Int J Antimicrob Agents. 2019 Oct;54(4):410-422. doi: 10.1016/j.ijantimicag.2019.08.012. Epub 2019 Aug 9. Review.

41.

The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1.

Welte T, Tuck AC, Papasaikas P, Carl SH, Flemr M, Knuckles P, Rankova A, Bühler M, Großhans H.

Genes Dev. 2019 Sep 1;33(17-18):1221-1235. doi: 10.1101/gad.328492.119. Epub 2019 Aug 1.

42.

Pleural Effusion in Adults-Etiology, Diagnosis, and Treatment.

Jany B, Welte T.

Dtsch Arztebl Int. 2019 May 24;116(21):377-386. doi: 10.3238/arztebl.2019.0377.

43.

Consequences of chronic kidney disease in chronic obstructive pulmonary disease.

Trudzinski FC, Alqudrah M, Omlor A, Zewinger S, Fliser D, Speer T, Seiler F, Biertz F, Koch A, Vogelmeier C, Welte T, Watz H, Waschki B, Fähndrich S, Jörres R, Bals R; German COSYCONET consortium.

Respir Res. 2019 Jul 12;20(1):151. doi: 10.1186/s12931-019-1107-x.

44.

SERPINA1 gene polymorphisms in a population-based ALSPAC cohort.

DeLuca DS, Poluzioroviene E, Taminskiene V, Wrenger S, Utkus A, Valiulis A, Alasevičius T, Henderson J, Bush A, Welte T, Janciauskiene S, Valiulis A.

Pediatr Pulmonol. 2019 Sep;54(9):1474-1478. doi: 10.1002/ppul.24422. Epub 2019 Jul 12.

PMID:
31298815
45.

Combined effects of lung function, blood gases and kidney function on the exacerbation risk in stable COPD: Results from the COSYCONET cohort.

Trudzinski FC, Kahnert K, Vogelmeier CF, Alter P, Seiler F, Fähndrich S, Watz H, Welte T, Speer T, Zewinger S, Biertz F, Kauczor HU, Jörres RA, Bals R; COSYCONET consortium.

Respir Med. 2019 Jul - Aug;154:18-26. doi: 10.1016/j.rmed.2019.06.007. Epub 2019 Jun 11.

PMID:
31203096
46.

PCR-based routine diagnostics uncover hidden burden of Legionnaires' disease.

Pletz MW, Ewig S, Welte T.

Lancet Infect Dis. 2019 Jul;19(7):681-683. doi: 10.1016/S1473-3099(19)30171-9. Epub 2019 Jun 10. No abstract available.

PMID:
31196814
47.

Left heart function in COPD : Impact of lung deflation.

Struß N, Bauersachs J, Welte T, Hohlfeld JM.

Herz. 2019 Sep;44(6):477-482. doi: 10.1007/s00059-019-4816-5.

PMID:
31187193
48.

Serum Levels of Alpha1-antitrypsin and Their Relationship With COPD in the General Spanish Population.

Janciauskiene S, DeLuca DS, Barrecheguren M, Welte T, Miravitlles M; Scientific Committee; Participating sites and coordinators.

Arch Bronconeumol. 2020 Feb;56(2):76-83. doi: 10.1016/j.arbres.2019.03.001. Epub 2019 May 30. English, Spanish.

PMID:
31153743
49.

Extracorporeal membrane oxygenation for acute respiratory distress syndrome due to Pneumocystis pneumonia.

Stahl K, Schenk H, Seeliger B, Wiesner O, Schmidt JJ, Bauersachs J, Welte T, Kühn C, Haverich A, Hoeper MM, David S.

Eur Respir J. 2019 Sep 19;54(3). pii: 1900410. doi: 10.1183/13993003.00410-2019. Print 2019 Sep. No abstract available.

PMID:
31151957
50.

MRI-derived regional flow-volume loop parameters detect early-stage chronic lung allograft dysfunction.

Moher Alsady T, Voskrebenzev A, Greer M, Becker L, Kaireit TF, Welte T, Wacker F, Gottlieb J, Vogel-Claussen J.

J Magn Reson Imaging. 2019 Dec;50(6):1873-1882. doi: 10.1002/jmri.26799. Epub 2019 May 27.

PMID:
31134705

Supplemental Content

Support Center